e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Asthma: new mechanisms and markers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients
F. Schwingel, M. Pizzichini, E. Pizzichini, S. Leila, E. Morato, C. Rocha, T. Kleveston, J. Pinheiro (Florianopolis, Brazil)
Source:
Annual Congress 2013 –Asthma: new mechanisms and markers
Session:
Asthma: new mechanisms and markers
Session type:
Thematic Poster Session
Number:
591
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Schwingel, M. Pizzichini, E. Pizzichini, S. Leila, E. Morato, C. Rocha, T. Kleveston, J. Pinheiro (Florianopolis, Brazil). PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients. Eur Respir J 2013; 42: Suppl. 57, 591
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Investigation the role of pentraxin-3 in the innate immune system in patients with COPD
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Presence of progranulin in airway inflammation associated with COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Alterations of the soluble proteome of airway epithelial cells in COPD
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Cytotoxic activity and oxidative DNA damage in smoking asthmatics versus COPD patients
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Peripheral blood eosinophilia predicts lower airway eosinophilia in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
Cytokine patterns and latent viruses in patients with severe asthma and COPD
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Sputum induction elicits different peripheral airways responses in healthy subjects, asthma and allergic rhinitis patients
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
T
H
2 specific biomarker profile determines steroid responsiveness in severe asthma
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Comparing the effects of oxidative stress on mitochondrial function and antiviral responses in primary bronchial epithelial cells of asthmatics and non-asthmatics
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Association between qPCR bacterial load and airway inflammation in COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients
Source: International Congress 2016 – From microimaging to functional evaluation of the lung
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept